Literature DB >> 15319073

A novel monoclonal antibody against canine monocytes/macrophages.

Paulo Henrique Palis Aguiar1, Roberto Robson Borges dos Santos, Daniela Farias Larangeira, Marta Almeida dos Santos, Stella Maria Barrouin-Melo, Tânia Maria Correia Silva, José O Mengel, Washington Luis Conrado dos Santos, Lain Pontes-de-Carvalho.   

Abstract

The production and partial characterization of a monoclonal antibody, the IgG1 IH1, which recognizes an antigen distributed in canine monocytes/macrophages, is reported here. The distribution and apparent molecular weight of the antigen recognized by the IH1 MAb was determined in peripheral blood leukocytes, peripheral blood monocyte-derived macrophages and tissue sections of spleen, liver and skin, using Western blotting, immunocytochemistry, immunohistochemistry and flow cytometry. The IH1 MAb-recognized antigen was detected in Western blotting under non-reducing conditions spread out as a large band covering the position corresponding to the migration of molecules with molecular weights from 55 to 73 kDa. The IH1 MAb labeled blood monocytes, tissue macrophages in lymph nodes, and in the mantle zone of the spleen, and Kupffer cells in the liver. It did not react with human cells. In flow cytometric analysis, the IH1 MAb reacted with a subpopulation of monocytes. The MAb described herein may become a valuable tool for diagnosis and research on canine diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319073     DOI: 10.1089/1536859041651303

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  2 in total

1.  Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Authors:  Edilberto Postól; André Meyer; Fabíola Cardillo; Raquel de Alencar; Daniel Pessina; Jorge Nihei; Mário Mariano; José Mengel
Journal:  Immunology       Date:  2008-04-07       Impact factor: 7.397

2.  A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesis.

Authors:  Breno C B Beirão; Teresa P Raposo; Louise M Imamura; Max Ingberman; Ted Hupp; Bořivoj Vojtěšek; David J Argyle
Journal:  Antib Ther       Date:  2020-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.